• calixlifesciences1.png
  • new_banner copy.jpg
  • new_banner copy1.jpg
  • new_banner copy_1.jpg
  • new_banner copy_2.png
  • new_banner copy_3.jpg

OcunepaTM Eye Drops

 

Composition:

 

 

Nepafenac …………………………………………………0.1% w/v

 

 

Benzalkonium Chloride Solution I.P. …………. 0.01% v/v

 

(As Preservative)

 

 

Aqueous Buffered Vehicle ………………………… Q.S.

 

 

Explore the Unmatched Advantage with OcunepaTM

 


 

 

OcunepaTM contains Nepafenac 0.1% w/v which is act as a pro-drug with superior penetration of the cornea & scleral tissues.

 

 

Nepafenac has approved by USFDA for the treatment of pain and inflammation associated with cataract surgery.

 

 

OcunepaTM inhibits both COX-1 & COX-2 activity as well as preventing vision loss due to Diabetic Macular Edema.

 

 

OcunepaTM ………………NSAID designed for Eyes.

 


 

 

Indications:

 

 

Diabetic Macular Edema

 

 

Post operative care

 

 

CME (Cystoid Macular Edema)

 

  • Acuvita.jpg
  • brimofine-t.jpg
  • ebri-tab.png
  • fedcef.png
  • flurostar_eye_drops.jpg
  • Gaticheck.jpg
  • lacricool_eye_drops.jpg
  • lavotears_eye.jpg
  • lavotears_gel.jpg
  • lavoters-eye-oentment.png
  • limaclav.png
  • limaclavp-dry-syrup.png
  • limaflam-tab.png
  • lricain.jpg
  • ocunepa_eye_drops.jpg
  • olspore_od.jpg
  • optipred_eye_drops.jpg
  • supervisc.jpg
  • timogold_eye_drops.jpg
  • vodamox-eye-oentment.png
  • vodamox-T.png
  • vodamox_eye_drops.jpg
  • vodamox_lp.jpg
  • vodamox_plus.jpg
  • winsight-tab.png
Powered by : WDSoft